Yihua Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yihua Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Qiao Ye
Clinical Center for Interstitial Lung Diseases, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
2 shared publications Chunming Zheng
Medical Research Center, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, No.8 Worker’s Stadium, Chaoyang District, Bejing, China
1 shared publicationDandan Chai
Clinical Center for Interstitial Lung Diseases, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
1 shared publication- Jing Wang
Mass General Cancer Center, Mass General Brigham, Harvard Medical School, Somerville, Massachusetts, USA
1 shared publication - Li-Ming Zhang
Hunan University of Medicine, Huaihua, Hunan, 410208, China
1 shared publication - Na Wu
Department of Occupational Medicine and Toxicology, Clinical Center for Interstitial Lung Diseases, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, No.8 Worker’s Stadium, Chaoyang District. Beijing, China
1 shared publication
Latest Publications
- 27 November 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 41 (3) , 783-793
Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study
Objectives This study aimed to explore differences in clinical features and prognosis among patients with varied myeloperoxidase (MPO) antineutrophil cytoplasmic antibody-associated vasculitis (MPO-AAV) associated lung diseases. Methods Patients with MPO-AAV-associated lung diseases were enrolled in this retrospective cohort study at a single center. Clinical features and laboratory data at the time of diagnosis were compared among patients with various lung disease patterns. Kaplan–Meier and Cox regression analyses were performed to analyze overall survival. Results A total of 155 patients were finally included and categorized into five groups, as follows: 72 had a usual interstitial pneumonia (UIP) pattern, 40 had non-UIP interstitial pneumonia, 18 had bronchiectasis (BR), 13 had necrotizing granuloma (NG), and 12 had diffuse alveolar hemorrhage (DAH). Among the five groups, patients with DAH had higher dyspnea and hemoptysis frequencies, lower PaO2/FiO2 levels, elevated C-reactive protein levels, and the poorest prognosis. The overall survival (OS) in the DAH group (median OS: 3.2 months) was significantly poorer than that in the NG group (median OS: not reached, log rank P < 0.001), the BR group (median OS: not reached, log rank P < 0.001), and the non-UIP IP group (median OS: 61.1 months, log rank P = 0.001). The UIP group had significantly more ex-smokers than the other groups (P < 0.001) and the second poorest survival (median OS: 39.1 months). The NG group tended to have female predominance, a higher incidence of ENT involvement, less severe renal involvement, and the best survival. After adjusting for multi-model Cox regression analysis, DAH and UIP (hazard ratio: 19.301 and 9.940, respectively, compared with NG) were independent predictors of all-cause mortality. Conclusions Various patterns of lung disease-associated MPO-AAV may potentially predict patient survival. Key Point • The present study described the clinical and prognostic features of various lung diseases-associated MPO-AAV, indicating the potential prediction for the survival of MPO-AAV patients.
- 27 November 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 41 (3) , 783-793
Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study
Objectives This study aimed to explore differences in clinical features and prognosis among patients with varied myeloperoxidase (MPO) antineutrophil cytoplasmic antibody-associated vasculitis (MPO-AAV) associated lung diseases. Methods Patients with MPO-AAV-associated lung diseases were enrolled in this retrospective cohort study at a single center. Clinical features and laboratory data at the time of diagnosis were compared among patients with various lung disease patterns. Kaplan–Meier and Cox regression analyses were performed to analyze overall survival. Results A total of 155 patients were finally included and categorized into five groups, as follows: 72 had a usual interstitial pneumonia (UIP) pattern, 40 had non-UIP interstitial pneumonia, 18 had bronchiectasis (BR), 13 had necrotizing granuloma (NG), and 12 had diffuse alveolar hemorrhage (DAH). Among the five groups, patients with DAH had higher dyspnea and hemoptysis frequencies, lower PaO2/FiO2 levels, elevated C-reactive protein levels, and the poorest prognosis. The overall survival (OS) in the DAH group (median OS: 3.2 months) was significantly poorer than that in the NG group (median OS: not reached, log rank P < 0.001), the BR group (median OS: not reached, log rank P < 0.001), and the non-UIP IP group (median OS: 61.1 months, log rank P = 0.001). The UIP group had significantly more ex-smokers than the other groups (P < 0.001) and the second poorest survival (median OS: 39.1 months). The NG group tended to have female predominance, a higher incidence of ENT involvement, less severe renal involvement, and the best survival. After adjusting for multi-model Cox regression analysis, DAH and UIP (hazard ratio: 19.301 and 9.940, respectively, compared with NG) were independent predictors of all-cause mortality. Conclusions Various patterns of lung disease-associated MPO-AAV may potentially predict patient survival. Key Point • The present study described the clinical and prognostic features of various lung diseases-associated MPO-AAV, indicating the potential prediction for the survival of MPO-AAV patients.
- 15 December 2020
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 78 (5) , 342-348
Telomerase gene variants and telomere shortening in patients with silicosis or asbestosis
Objectives: Telomerase gene variants that lead to accelerated telomere shortening are linked to progressive-fibrosing interstitial lung diseases. However, little is known about their relationships with pneumoconiosis. This study aimed to identifyTERT/TERCvariants and leucocyte telomere lengths (LTL) in patients with silicosis or asbestosis.Methods: In the present study, Sanger sequencing ofTERT/TERCvariants was performed in 193 Chinese Han patients with pneumoconiosis, including 109 with silicosis and 84 with asbestosis. Quantitative PCR was used to measure LTL in peripheral blood of the patients and 200 age and sex-matched healthy controls.Results: In total, 7.3% patients with pneumoconiosis had 17TERT/TERCvariants. Among which 8.3% of patients with silicosis and 3.6% of patients with asbestosis hadTERTvariants, respectively. NoTERCvariants were detected in silicosis, whereas 3.6% of patients with asbestosis hadTERCvariants. Telomeres were significantly shorter in the patients with pneumoconiosis compared with healthy controls (pTERT/TERCvariant carriers and non-carriers. Exposure to silica dust was associated with the severity of pneumoconiosis after adjusting for covariates (OR 4.92, p=0.002). However,TERT/TERCvariants and short telomeres were not associated with the severity of pneumoconiosis.Conclusion: Telomerase gene variants and short telomeres may be identified in the patients with silicosis and asbestosis in response to the exposure to silica or asbestos dust but are not related to disease severity.
- 15 December 2020
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 78 (5) , 342-348
Telomerase gene variants and telomere shortening in patients with silicosis or asbestosis
Objectives: Telomerase gene variants that lead to accelerated telomere shortening are linked to progressive-fibrosing interstitial lung diseases. However, little is known about their relationships with pneumoconiosis. This study aimed to identifyTERT/TERCvariants and leucocyte telomere lengths (LTL) in patients with silicosis or asbestosis.Methods: In the present study, Sanger sequencing ofTERT/TERCvariants was performed in 193 Chinese Han patients with pneumoconiosis, including 109 with silicosis and 84 with asbestosis. Quantitative PCR was used to measure LTL in peripheral blood of the patients and 200 age and sex-matched healthy controls.Results: In total, 7.3% patients with pneumoconiosis had 17TERT/TERCvariants. Among which 8.3% of patients with silicosis and 3.6% of patients with asbestosis hadTERTvariants, respectively. NoTERCvariants were detected in silicosis, whereas 3.6% of patients with asbestosis hadTERCvariants. Telomeres were significantly shorter in the patients with pneumoconiosis compared with healthy controls (pTERT/TERCvariant carriers and non-carriers. Exposure to silica dust was associated with the severity of pneumoconiosis after adjusting for covariates (OR 4.92, p=0.002). However,TERT/TERCvariants and short telomeres were not associated with the severity of pneumoconiosis.Conclusion: Telomerase gene variants and short telomeres may be identified in the patients with silicosis and asbestosis in response to the exposure to silica or asbestos dust but are not related to disease severity.